Sclc: Combination of Cisplatin and Etoposide is the first line therapy for small cell lung cancer. It is also one of regimens we use for non small cell lung cancer. Thus, this regimen will take care both. It is important however to make sure that your oncologist get more information including type ( adeno vs squamous etc), some molecular evaluations ( egfr, alk, ross-1) to the nsclc on the right lung.
Answered 6/25/2014
4.9k views
Standard: The use of Cisplatin and Etoposide in small cell lung cancer is a standard often used regimen.
Answered 6/25/2014
4.9k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question